About this trial
This project capitalizes on principles of control systems engineering to build a dynamical model that predicts weight change during weight loss maintenance using behavioral, psychosocial, and environmental indicators evaluated in a system identification experiment. A 6-month behavioral obesity treatment will be administered to produce weight loss. Participants losing at least 3% of initial body weight will be followed for an additional 12 months via daily smartphone surveys that incorporates passive sensing to objectively monitor key behaviors. Survey data pertaining to behavioral, psychosocial, and environmental indicators will be used to develop a controller algorithm that can predict when an individual is entering a heightened period of risk for regain and why risk is elevated. Interventions targeting key risk indicators will be randomly administered during the system ID experiment. Survey and passive sensing data documenting the effects of the interventions will likewise drive development of the controller algorithm, allowing it to determine which interventions are most likely to counter risk of regain.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
English language fluent and literate at the 6th grade level
Body mass index (BMI) between 25 and 50 kg/m-squared
Able to walk 2 city blocks without stopping
Owns a smartphone
Disqualifiers
Report of a heart condition, chest pain during periods of activity or rest, or loss of consciousness in the 12 months prior to enrolling.
Currently participating in another weight loss program
Currently taking weight loss medication
Has lost ≥5% of body weight in the 6 months prior to enrolling
Trial design
Single group
Treatments tested in this trial
Intervention Targeting Stress and Emotion Regulation
BehavioralThis intervention involves learning and practicing relaxation exercises and setting aside time for pleasurable activities.
Intervention Targeting Motivation and Self-efficacy for Weight Management
BehavioralThis intervention involves identifying values related to weight, lifestyle, and health; identifying barriers to value-consistent living; exploring the consequences of letting barriers drive behavior; and 4) setting goals that are small, specific, attainable, and values-consistent.
Intervention for Normalization of Eating
BehavioralThis intervention involves dietary self-monitoring with the goal of staying within a calorie goal ranging from 1,200 kcal/day to 1,800 kcal/day. Participants are also provided with meal planning tools and encouraged to addresses hunger and cravings by promoting feelings of satiety via consumption of foods that are high in volume but low in calories.
Intervention Targeting Physical Activity and Sleep
BehavioralThis simple intervention prompts participants at the start of the day to schedule up to 30 minutes of moderate-to-vigorous intensity physical activity; brisk walking is encouraged. Participants also set a bedtime and wake time and are encouraged to set a reminder alarm to ensure at least 8 hours of sleep.
Treatment groups
Trial outcomes
Primary outcomes
Weight change
This will be measured throughout the system identification experiment using a consumer scale with internet connectivity.
Secondary outcomes
Intervention engagement
Intervention engagement will be measured by the smartphone application that delivers intervention. Engagement is defined as the count of clicks to open intervention resources.
Weight Locus of Control
Mean scale score of questionnaire items adapted from the Multidimensional Health Locus of Control scale for smartphone administration.
Perceived Benefit of Weight Control
Mean scale score of questionnaire items adapted from the Beliefs about Dietary Compliance Scale and the Exercise Benefits/Barriers scale for smartphone administration.
Weight Control Strategies Intentions and Implementation
Mean scale score of questionnaire items adapted from the Weight Control Strategies scale for smartphone administration.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
The Miriam Hospital
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator